Cnn
–
The White House designates Dr. Susan Monarez, the current acting director of US Centers for Disease Control and Prevention, to lead the agency, said President Donald Trump on Monday.
This decision comes for weeks after the White House suddenly withdrawn from Dr. Dave Weldon to direct the public health agency.
Monarez is a veteran of government services that was previously deputy director From Arpa-H, the Advanced Research Projects Agency for Health, an agency responsible for doing innovative and high issues.
“Dr. Monarez brings decades of experience in the Champion of innovation, transparency and solid public health systems. She has a doctorate from the University of Wisconsin, and a postdoctoral training in microbiology and immunology at the Stanford University School of Medicine “, Trump”, Trump Posted on Truth Social.
Affirming that the Americans have “lost confidence in the CDC because of political prejudices and disastrous mismanagement,” he added: “Dr. Monarez will work in close collaboration with our great secretary for health and social services, Robert Kennedy Jr. Together, they will favor responsibility, high standards and disease prevention”.
This year is the first time that the CDC director has been demanding confirmation of the Senate; In the past, the CDC director was appointed to lead the agency and did not need to go through an audience and vote in the Senate.
Earlier this month, the White House withdrew His appointment of Weldon after the managers of the White House expressed private concerns concerning his comments expressing skepticism concerning vaccines. Even Kennedy, who has a long history of questioning vaccines, had concerns, according to sources.
The reactions to the choice of Monarez to direct the country of the country’s public health were mixed. Some members of the public health community have applauded the decision.
“Susan has a long and distinguished history as an effective and data-oriented civil servant,” wrote Jennifer Nuzzo, professor of epidemiology and director of the Pandemic Center at the Brown University School of Public Health, in an email. “I am delighted to learn that she will direct the CDC.”
Dr Tom InglesbyDirector of the Johns Hopkins Center for Health Security at the Bloomberg School of Public Health, described Monarez as “a very good scientist and a very competent person”.
Inglesby, who was an advisor to HHS, the Ministry of Defense and the Ministry of Homeland Security, as well as the Biden administration on the COVI-19 response, said that he had known Monarez to work with her for many years in his management roles in the government.
“She is very attached to public health and good government,” he said. “Politics is not his thing.”
But some CDC staff expressed more reservations on Monday, asking anonymity to concern their work.
A main concern was that Monarez had not had a major presence at the agency, an employee saying that the perception was that, as an acting director, Monarez had been more a “emotial” than a competitor for the first job. And they feared not defending the agency against the cuts provided for its funding and its workforce.
“It was a non-entity,” said a senior health official. “I’m not sure she left the White House.”
The Atlanta -based agency was under the breath Releases, breaks in financing and communications is freezing in the past two months, and it is preparing for deeper cuts within the framework of the planned reductions in force through the federal government – which all have the potential for hamstrings to a future leader.
“If Susan receives latitude, which means freedom to make her own decisions based on science and evidence, the budget she needs, and if she is able to maintain the expert workforce,” added Inglesby, “I think she will be a strong leader for the CDC.”
Alayna Treene and Kit Maher of CNN contributed to this report.